Pharma News

Gujarat FDCA appoints 156 staff in one go to avoid backlog in samples testing

The Gujarat Food and Drug Control Administration (FDCA) has completed a mass recruitment process in the first week of March by giving away appointment letters to 156 candidates in one go, probably the biggest recruitment since the inception of the administration, in a move to hasten the monitoring activities of food and drugs marketed in the state.

DoP calls meeting on March 2 to discuss MS Pharmacy issue

Even as hundreds of MS (Pharmacy) students of all the NIPERs in the country are on a silent strike to put pressure on the authorities to resolve the issues arising out of the PCI's recent decision not to recognize the MS programme in Industrial Pharmaceutics and Pharmaceutical Analysis & Quality Control, the department of pharmaceuticals (DoP) has called a meeting on March 2 to discuss the issue in threadbare.

Govt to constitute National Apex Committee for monitoring stem cell research soon

Almost two years after announcing the Guidelines for Stem Cell Research Regulation, prescribing stringent procedures for souring and use of stem cells by research institutions in the country, the union health ministry is yet to constitute the National Apex Committee (NAC) for effectively reviewing and monitoring the stem cell research in the country.

US FDA approves velaglucerase alfa for injection to treat rare genetic disorder Gaucher disease

The US Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease.

Gaucher disease occurs in people who do not produce enough of an enzyme called glucocerebrosidase. Without this enzyme, harmful amounts of a certain fatty substance (lipid) can build up in the liver, spleen, bones, bone marrow and nervous system, and can prevent cells and organs from working properly. About one in 50,000 to one in 100,000 people in the general population have Gaucher disease.